These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 2422778
1. Tolerance and biological activity of pentosan polysulfate after intramuscular or subcutaneous administration for ten days in human volunteers. Sié P, Albarede JL, Robert M, Bouloux C, Lansen J, Chigot C, Correll S, Thouvenot JP, Boneu B. Thromb Haemost; 1986 Feb 28; 55(1):86-9. PubMed ID: 2422778 [Abstract] [Full Text] [Related]
2. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection. Fischer AM, Merton RE, Marsh NA, Williams S, Gaffney PJ, Barrowcliffe TW, Thomas DP. Thromb Haemost; 1982 Apr 30; 47(2):109-13. PubMed ID: 6179183 [Abstract] [Full Text] [Related]
3. Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteers. Harenberg J, Giese C, Dempfle CE, Stehle G, Heene DL. Thromb Haemost; 1989 Jun 30; 61(3):357-62. PubMed ID: 2552604 [Abstract] [Full Text] [Related]
4. Absence of transplacental passage of pentosan polysulfate during mid trimester of pregnancy. Forestier F, Fischer AM, Daffos F, Beguin S, Diner H. Thromb Haemost; 1986 Dec 15; 56(3):247-9. PubMed ID: 2436327 [Abstract] [Full Text] [Related]
5. Comparative turn-over of heparin cofactor II and antithrombin III in baboons. Influence of heparin and pentosan polysulfate administration. Sié P, Lansen J, Lacheretz F, Verschuere B, Boneu B. Thromb Haemost; 1986 Dec 15; 56(3):302-7. PubMed ID: 2436331 [Abstract] [Full Text] [Related]
6. Effect of pentosan polysulphate administration in man on the formation of covalent complexes between heparin cofactor II and thrombin generated in plasma by contact activation. Dol F, Sié P, Dupouy D, Boneu B. Thromb Haemost; 1986 Dec 15; 56(3):295-8. PubMed ID: 2436330 [Abstract] [Full Text] [Related]
7. The effect of pentosan polysulphate (SP54) on the fibrinolytic enzyme system--a human volunteer and experimental animal study. Marsh NA, Peyser PM, Creighton LJ, Mahmoud M, Gaffney PJ. Thromb Haemost; 1985 Dec 17; 54(4):833-7. PubMed ID: 2418527 [Abstract] [Full Text] [Related]
8. Chrono-pharmacological study of once daily curative dose of a low molecular weight heparin (200 IU antiXa/kg of Dalteparin) in ten healthy volunteers. Mismetti P, Reynaud J, Tardy-Ponce B, Laporte-Simitsidis S, Scully M, Goodwyn C, Queneau P, Decousus H. Thromb Haemost; 1995 Aug 17; 74(2):660-6. PubMed ID: 8585003 [Abstract] [Full Text] [Related]
13. Metabolism of sodium pentosan polysulphate in man measured by a new competitive binding assay for sulphated polysaccharides--comparison with effects upon anticoagulant activity, lipolysis and platelet alpha-granule proteins. MacGregor IR, Dawes J, Pepper DS, Prowse CV, Stocks J. Thromb Haemost; 1985 Jun 24; 53(3):411-4. PubMed ID: 2413564 [Abstract] [Full Text] [Related]
17. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model. McGlasson DL, Harroff HH, Sutton J, Dick E, Elston DM. Clin Lab Sci; 2007 Jun 24; 20(2):99-105. PubMed ID: 17557708 [Abstract] [Full Text] [Related]
18. Localization of the inhibitory site(s) of pentosan polysulphate in blood coagulation. Wagenvoord R, Hendrix H, Soria C, Hemker HC. Thromb Haemost; 1988 Oct 31; 60(2):220-5. PubMed ID: 2464199 [Abstract] [Full Text] [Related]